I
Innerskin
Innerskin pioneers a new generation of aesthetic medicine, placing skin health at the core of its practice
About Innerskin
Innerskin, established in 2022 by founder and CEO Chrystelle Eid, is a Paris-based company operating in the aesthetic medicine sector. Drawing from her background in finance, including a Master's in Quantitative Economics and Finance from HEC Paris and roles at Carmignac and Charterhouse Capital Partners, Eid identified a gap in the European market for technology-driven aesthetic services. Innerskin positions itself as a new generation of medical aesthetic centers, focusing on skin health as the foundation of beauty.
The company's business model is direct-to-consumer (B2C), providing non-invasive aesthetic treatments performed by medical professionals. Revenue is generated through the provision of these services and the sale of its own skincare product line. Clients receive personalized treatment protocols that may include services like laser treatments, peels, injections, cryolipolysis, and advanced facial treatments like Hydrafacial. Beyond individual treatments, Innerskin also offers its own range of skincare products inspired by mesotherapy, categorized into cleansing, treating, and preserving functions, as well as a hydrolyzed collagen supplement.
The company has demonstrated rapid growth since its first location opened in Paris in September 2022. By late 2023, Innerskin had expanded to nine locations across France, including several clinics in Paris, and partnerships with hotels and the Galeries Lafayette department store. This expansion was fueled by two funding rounds, totaling €8 million, with the latest €5 million round led by Label Capital. This capital is intended to support the opening of more clinics, with plans for international expansion.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2025 | $14M | $57M | IRIS Ventures · Label Capital | ↗ |
| SEED✓Equity / VC | Jan 2024 | $3.3M | $13M | Label Capital | ↗ |
Growth signals
Latest recorded traffic for Innerskin is 36K monthly website visits, down 35.7% over the last three months. Innerskin's team grew 10.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Label Capital
Series A1 investor entered at this stage
IRIS Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Innerskin on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Innerskin’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







